Clinical trial · Interventional
Low Intensity Aerobic Exercise and Active Exercises in Cancer Patients Receiving Palliative Care
Comparison of Low Intensity Aerobic Exercise and Active Exercises on Cancer Related Fatigue in Cancer Patients Receiving Palliative Care
NCT05059990CI-TRIAL-00056277completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To compare the effect of low intensity aerobic exercise and active ROM exercises on cancer related fatigue and its associated symptoms and quality of life in cancer patients receiving palliative care.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Active Exercises Group | Other | — | UNRESOLVED |
| Low Intensity Aerobic Exercises Group | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Low Intensity Aerobic Exercises Group
- description
- stationary cycle for aerobic exercise
- interventionNames
- Other: Low Intensity Aerobic Exercises Group
- type
- ACTIVE_COMPARATOR
- label
- Active Exercises Group
- description
- Upper and lower limb range of Motion (ROM) \& stretching exercises uses in active exercise group
- interventionNames
- Other: Active Exercises Group
Primary outcomes (4)
- measure
- Fatigue Numeric Rating Scale
- timeFrame
- 4th Week
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * ability to give written consent. * Diagnosed advance cancer specifically gastrointestinal tract (GIT) cancer, Lung cancer and Breast cancer etc. (stage 2 and 3). * Intensity of fatigue ≥4 out of 10 on fatigue Numerical Rating Scale in first visit observation * Survival expectancy more than one month, * Functional status allowing the participants to participate in the proposed therapy. Exclusion Criteria: * Anemia (Hb ≤ 8g/dl), * Existence of other comorbidities causing fatigue (i.e. Parkinson's, Multiple sclerosis, Heart failure), * Infection requiring antibodies * bone metastases, * thrombocytopenia (\<50×109/l), * myocardial infarction within the past three months * uncontrolled hypertension (diastolic pressure \>95 mm Hg).
References
Publications (0)
Data not yet available
No reference posted for this study.